These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24523790)

  • 1. A brief overview of methamphetamine use treatment in Iran: Intervention and practice.
    Mehrjerdi ZA
    J Res Med Sci; 2013 Dec; 18(12):1018-20. PubMed ID: 24523790
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of a Brief Home-Based Social Work Motivational Intervention for Male Methamphetamine Users in Tehran: A Randomized Clinical Trial.
    Danaee-Far M; Maarefvand M; Rafiey H
    Subst Use Misuse; 2016 Dec; 51(14):1863-9. PubMed ID: 27608368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial.
    Kheirabadi GR; Bahrami M; Shariat A; Tarrahi M
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):45-48. PubMed ID: 33347022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country.
    Alam-Mehrjerdi Z; Abdollahi M
    Daru; 2015 Nov; 23():51. PubMed ID: 26578071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine Use among Iranian Youth: A Population-based Knowledge, Attitude, and Practice study.
    Sharifi H; Shokoohi M; Ahmad RafieiRad A; Sargolzaie Moghadam M; Haghdoost AA; Mirzazadeh A; Karamouzian M
    Subst Use Misuse; 2017 Jul; 52(9):1232-1239. PubMed ID: 28605272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of add-on valproate on craving in methamphetamine depended patients: A randomized trial.
    Kheirabadi GR; Ghavami M; Maracy MR; Salehi M; Sharbafchi MR
    Adv Biomed Res; 2016; 5():149. PubMed ID: 27656618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal in Iran: methamphetamine or heroin kerack.
    Alam Mehrjerdi Z
    Daru; 2013 Mar; 21(1):22. PubMed ID: 23497450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country.
    Alam-mehrjerdi Z; Mokri A; Dolan K
    Asian J Psychiatr; 2015 Aug; 16():17-25. PubMed ID: 26123235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial.
    Sorsdahl K; Stein DJ; Pasche S; Jacobs Y; Kader R; Odlaug B; Richter S; Myers B; Grant JE
    Addict Sci Clin Pract; 2021 Jan; 16(1):3. PubMed ID: 33413631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the sequential patterns of methamphetamine use initiation in Iran.
    Sarani EM; Ahmadi J; Oji B; Mahi-Birjand M; Bagheri N; Bazrafshan A; Manshadi MD; Yaghoubi S; Dezhkam A; Khatami M; Abdollahpour-Alitappeh M
    Subst Abuse Treat Prev Policy; 2020 Jul; 15(1):52. PubMed ID: 32727512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients.
    Zarrabi H; Khalkhali M; Hamidi A; Ahmadi R; Zavarmousavi M
    BMC Psychiatry; 2016 Feb; 16():44. PubMed ID: 26911516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of inpatients with methamphetamine-induced psychosis.
    Fasihpour B; Molavi S; Shariat SV
    J Ment Health; 2013 Aug; 22(4):341-9. PubMed ID: 23323572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of a methamphetamine crisis in Iran.
    Shariatirad S; Maarefvand M; Ekhtiari H
    Drug Alcohol Rev; 2013 Mar; 32(2):223-4. PubMed ID: 23190186
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study.
    Noroozi A; Malekinejad M; Rahimi-Movaghar A
    J Psychoactive Drugs; 2018; 50(3):214-223. PubMed ID: 29377788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of impurities in illicit methamphetamine samples seized in Iran.
    Khajeamiri AR; Faizi M; Sohani F; Baheri T; Kobarfard F
    Forensic Sci Int; 2012 Apr; 217(1-3):204-6. PubMed ID: 22153622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and factors associated with methamphetamine use among adult substance abusers.
    Barati M; Ahmadpanah M; Soltanian AR
    J Res Health Sci; 2014; 14(3):221-6. PubMed ID: 25209911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-associated psychosis: a new health challenge in Iran.
    Alam Mehrjerdi Z; Barr AM; Noroozi A
    Daru; 2013 Apr; 21(1):30. PubMed ID: 23577655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of blood lead level in methamphetamine users in Tehran.
    Mostafazadeh B; Shadnia S; Tavakkoli MA; Khoddami Vishteh HR
    Subst Abuse Treat Prev Policy; 2017 Feb; 12(1):2. PubMed ID: 28222753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative exploration of the factors associated with initiation to methamphetamine use in Iran.
    Shahbazi Sighaldeh S; Zarghami F; Shahryari A; Mohammadinia A; Ebrahimi M; Jorjani T; Hamrah MS; Charkazi A
    BMC Public Health; 2020 Nov; 20(1):1773. PubMed ID: 33228618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.